No Data
TD Cowen Initiates Coverage on RAPT Therapeutics With Buy Rating
TD Cowen Initiates RAPT Therapeutics(RAPT.US) With Buy Rating
TD Cowen Initiates a Buy Rating on RAPT Therapeutics (RAPT)
RAPT Therapeutics, Inc. (NASDAQ:RAPT) Surges 5.3%; Individual Investors Who Own 34% Shares Profited Along With Institutions
H.C. Wainwright Maintains RAPT Therapeutics(RAPT.US) With Buy Rating, Maintains Target Price $72
RAPT Therapeutics: Promising Pipeline and Superior Efficacy of Lead Candidate Ozureprubart